The rising prevalence in GLP-1 agonists for diabetes has sparked a discussion about delivery methods : skin-applied devices versus pills . Typically, GLP-1 therapies were only available in oral form, but https://reganwnhm993758.thelateblog.com/41308115/glp-1-transdermal-delivery-systems-vs-pills-is-best-for-individuals